SPRINGFIELD – The Illinois Department of Public Health (IDPH) is warning people about the dangers of synthetic cannabinoids, often called fake weed, K2, and spice, after six people who used synthetic cannabinoids suffered severe bleeding.

“Despite the perception that synthetic cannabinoids are safe and a legal alternative to marijuana, many are illegal and can cause severe illness,” said IDPH Director Nirav D. Shah, M.D., J.D. “The recent cases of severe bleeding are evidence of the harm synthetic cannabinoids can cause.”

Get The Latest News!

Don't miss our top stories and need-to-know news everyday in your inbox.

Article continues after sponsor message

Synthetic cannabinoids are not one drug, but hundreds of different chemicals manufactured and sold. These chemicals are called cannabinoids because they act on the same brain cell receptors as the main active ingredient in marijuana. Synthetic cannabinoid products are unsafe. It is difficult to know what’s in them or what your reaction to them will be. The health effects from using synthetic cannabinoids can be unpredictable and harmful—even life threatening.

Since March 10, 2018, six people in northeastern Illinois have suffered severe bleeding. All reported using synthetic cannabinoids. IDPH continues to investigate these cases to try to identify a common product.

Anyone who has a serious reaction to synthetic cannabinoids should call 911 or go to the emergency department immediately.

Prefer RiverBender on Google
Copyright 2026 Riverbender.com. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

 

More like this:

Podiatrist Explains Safe Ways to Remove Foot Calluses
Jun 2, 2026
IDPH Advises Precautions As Warm Weather Carries Increased West Nile, Rabies Risks
May 16, 2026
Illinois Maintains High Childhood Vaccination Rates, Outpacing National Trends
May 4, 2026
Centerstone’s ACT Program Helping Dozens Of Individuals With Severe Mental Illness
May 19, 2026
Plummer Blasts FY27 Budget Passage, Citing New Taxes and Closed-Door Negotiations
Jun 1, 2026